166 related articles for article (PubMed ID: 7860618)
1. Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer.
Lipponen PK; Liukkonen TJ
J Cancer Res Clin Oncol; 1995; 121(1):44-50. PubMed ID: 7860618
[TBL] [Abstract][Full Text] [Related]
2. Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens.
Tokunaga H; Shariat SF; Green AE; Brown RM; Zhou JH; Benedict WF; Lerner SP
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):16-22. PubMed ID: 11516846
[TBL] [Abstract][Full Text] [Related]
3. Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index.
Wright C; Thomas D; Mellon K; Neal DE; Horne CH
Br J Urol; 1995 Feb; 75(2):173-9. PubMed ID: 7850321
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer.
Lipponen PK
J Pathol; 1995 Feb; 175(2):203-10. PubMed ID: 7738716
[TBL] [Abstract][Full Text] [Related]
5. G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder.
Niehans GA; Kratzke RA; Froberg MK; Aeppli DM; Nguyen PL; Geradts J
Br J Cancer; 1999 Jun; 80(8):1175-84. PubMed ID: 10376969
[TBL] [Abstract][Full Text] [Related]
6. Expression of cathepsin D in transitional cell bladder tumours.
Lipponen PK
J Pathol; 1996 Jan; 178(1):59-64. PubMed ID: 8778318
[TBL] [Abstract][Full Text] [Related]
7. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value.
Lipponen P; Aaltomaa S; Eskelinen M; Ala-Opas M; Kosma VM
Eur Urol; 1998 Sep; 34(3):237-43. PubMed ID: 9732201
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.
Cordon-Cardo C; Wartinger D; Petrylak D; Dalbagni G; Fair WR; Fuks Z; Reuter VE
J Natl Cancer Inst; 1992 Aug; 84(16):1251-6. PubMed ID: 1640484
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838
[TBL] [Abstract][Full Text] [Related]
10. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of aberrations in p16/pRb pathway in urothelial bladder carcinomas: a multivariate analysis including p53 expression and proliferation markers.
Korkolopoulou P; Christodoulou P; Lazaris A; Thomas-Tsagli E; Kapralos P; Papanikolaou A; Kalliteraki I; Davaris P
Eur Urol; 2001 Feb; 39(2):167-77. PubMed ID: 11223676
[TBL] [Abstract][Full Text] [Related]
12. Expression of pS2 protein in transitional cell bladder tumours.
Lipponen PK; Eskelinen MJ
J Pathol; 1994 Aug; 173(4):327-32. PubMed ID: 7965392
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
14. Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma.
Lipponen P; Eskelinen M; Syrjänen K
Br J Cancer; 1995 Apr; 71(4):863-7. PubMed ID: 7710955
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis.
Lipponen PK; Aaltomaa S
J Pathol; 1994 Aug; 173(4):333-9. PubMed ID: 7965393
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
Lipponen PK; Eskelinen MJ
Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer.
Lipponen PK; Nordling S; Eskelinen MJ; Jauhiainen K; Terho R; Harju E
Int J Cancer; 1993 Jan; 53(1):42-7. PubMed ID: 8416203
[TBL] [Abstract][Full Text] [Related]
18. Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumours.
Lipponen PK; Aaltomaa S; Eskelinen M
Histopathology; 1996 Feb; 28(2):135-40. PubMed ID: 8834521
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer.
Pollack A; Czerniak B; Zagars GK; Hu SX; Wu CS; Dinney CP; Chyle V; Benedict WF
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):687-95. PubMed ID: 9336151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
